CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 475932-476275 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T49134","span":{"begin":0,"end":343},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The present study was designed to determine whether these or an additional 14 inflammatory mediators significantly differ in their brain levels and cellular expression between AD patients with mutations in the presenilin (PS1) gene (N=6) versus the more common sporadic disease (N=6) and to determine any relationship with the two pathologies."}

{"project":"Epistemic_Statements","denotations":[{"id":"T1059","span":{"begin":0,"end":343},"obj":"Epistemic_statement"}],"text":"The present study was designed to determine whether these or an additional 14 inflammatory mediators significantly differ in their brain levels and cellular expression between AD patients with mutations in the presenilin (PS1) gene (N=6) versus the more common sporadic disease (N=6) and to determine any relationship with the two pathologies."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T189","span":{"begin":0,"end":343},"obj":"Sentence"}],"text":"The present study was designed to determine whether these or an additional 14 inflammatory mediators significantly differ in their brain levels and cellular expression between AD patients with mutations in the presenilin (PS1) gene (N=6) versus the more common sporadic disease (N=6) and to determine any relationship with the two pathologies."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1028","span":{"begin":176,"end":178},"obj":"Phenotype"}],"attributes":[{"id":"A1028","pred":"hp_id","subj":"T1028","obj":"http://purl.obolibrary.org/obo/HP_0002511"}],"text":"The present study was designed to determine whether these or an additional 14 inflammatory mediators significantly differ in their brain levels and cellular expression between AD patients with mutations in the presenilin (PS1) gene (N=6) versus the more common sporadic disease (N=6) and to determine any relationship with the two pathologies."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T2088","span":{"begin":131,"end":136},"obj":"Body_part"}],"attributes":[{"id":"A2088","pred":"uberon_id","subj":"T2088","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"}],"text":"The present study was designed to determine whether these or an additional 14 inflammatory mediators significantly differ in their brain levels and cellular expression between AD patients with mutations in the presenilin (PS1) gene (N=6) versus the more common sporadic disease (N=6) and to determine any relationship with the two pathologies."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3023","span":{"begin":176,"end":178},"obj":"Disease"},{"id":"T15241","span":{"begin":176,"end":178},"obj":"Disease"}],"attributes":[{"id":"A3023","pred":"mondo_id","subj":"T3023","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A74676","pred":"mondo_id","subj":"T15241","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"}],"text":"The present study was designed to determine whether these or an additional 14 inflammatory mediators significantly differ in their brain levels and cellular expression between AD patients with mutations in the presenilin (PS1) gene (N=6) versus the more common sporadic disease (N=6) and to determine any relationship with the two pathologies."}